A better way to treat ACE inhibitor angioedema in the ED

14-05-2014 EurekAlert!Comments (0)


Emergency medicine and allergy experts at the University of Cincinnati have reported a safe and effective treatment for life-threatening angioedema attacks in the emergency department. In a triple blind, placebo-controlled phase-2 trial, researchers studied the drug Ecallantide for ACE inhibitor induced angioedema that failed to respond to the conventional therapy of corticosteroids and antihistamines. They found that patients treated with Ecallantide were more likely to meet discharge sooner and with few side effects.

Read more on EurekAlert!

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top